We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.26B
AUM Growth
-$39.6M
Cap. Flow
-$116M
Cap. Flow %
-5.13%
Top 10 Hldgs %
17.48%
Holding
313
New
24
Increased
42
Reduced
194
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 20.5%
2 Technology 18.67%
3 Industrials 18.53%
4 Consumer Discretionary 12.5%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTEK icon
1
Tetra Tech
TTEK
$8.33B
$56.1M 2.48%
6,030,460
-250,445
-4% -$2.2M
SUPN icon
2
Supernus Pharmaceuticals
SUPN
$2.6B
$49M 2.17%
1,224,317
-137,056
-10% -$5.93M
STMP
3
DELISTED
Stamps.com, Inc.
STMP
$42.4M 1.88%
209,123
-102,940
-33% -$18.9M
SFLY
4
DELISTED
Shutterfly, Inc.
SFLY
$38.9M 1.72%
801,520
+332,434
+71% +$15.6M
IDTI
5
DELISTED
Integrated Device Technology I
IDTI
$38.5M 1.7%
1,447,727
-65,730
-4% -$1.67M
LGND icon
6
Ligand Pharmaceuticals
LGND
$5.82B
$36.5M 1.61%
429,626
-18,223
-4% -$1.44M
LCII icon
7
LCI Industries
LCII
$2.46B
$36.2M 1.6%
312,076
+11,660
+4% +$1.19M
POOL icon
8
Pool Corp
POOL
$6.77B
$34.8M 1.54%
321,901
-11,888
-4% -$1.29M
CRTO icon
9
Criteo S.A. Ordinary Shares
CRTO
$1.09B
$33.1M 1.46%
797,529
-33,783
-4% -$1.61M
NKTR icon
10
Nektar Therapeutics
NKTR
$2.38B
$29.7M 1.31%
82,487
-3,494
-4% -$1.09M
TSEM icon
11
Tower Semiconductor
TSEM
$25.2B
$29.2M 1.29%
949,353
-90,256
-9% -$2.46M
EFOR
12
Everforth Inc
EFOR
$1.1B
$28.3M 1.25%
526,309
-25,073
-5% -$1.25M
ACHC icon
13
Acadia Healthcare
ACHC
$2.71B
$28M 1.24%
586,422
-24,170
-4% -$1.18M
ABCO
14
DELISTED
Advisory Board Co
ABCO
$27.2M 1.21%
508,041
-20,595
-4% -$1.11M
HCSG icon
15
Healthcare Services Group
HCSG
$1.57B
$26.4M 1.17%
489,218
-80,160
-14% -$4.12M
EBS icon
16
Emergent Biosolutions
EBS
$365M
$26M 1.15%
643,027
-26,590
-4% -$962K
CEVA icon
17
CEVA Inc
CEVA
$913M
$25.6M 1.13%
598,773
-27,104
-4% -$1.17M
TFX icon
18
Teleflex
TFX
$5.8B
$24.9M 1.1%
103,098
-4,583
-4% -$997K
PLAY icon
19
Dave & Buster's
PLAY
$375M
$24.3M 1.08%
463,477
+283,355
+157% +$16.9M
RAMP icon
20
LiveRamp
RAMP
$2.3B
$24M 1.06%
972,756
-45,601
-4% -$1.12M
CY
21
DELISTED
Cypress Semiconductor
CY
$23.8M 1.05%
1,582,537
-61,154
-4% -$856K
OZK icon
22
Bank OZK
OZK
$5.56B
$23M 1.02%
478,887
-18,227
-4% -$812K
AIN icon
23
Albany International
AIN
$2.11B
$22.6M 1%
394,396
-19,636
-5% -$1.05M
AX icon
24
Axos Financial
AX
$5.72B
$22.4M 0.99%
785,703
-23,949
-3% -$626K
FIVE icon
25
Five Below
FIVE
$11.8B
$21.9M 0.97%
398,407
-19,760
-5% -$967K

Similar funds

Rice Hall James & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Rice Hall James & Associates held 313 positions worth $2.26B, down 1.7% from $2.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Rice Hall James & Associates withdrew a net $116M in Q3 2017, closing 22 positions and reducing 194 holdings. Its most notable exit was Electronics for Imaging, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Knight Transportation worth $21.6M.

  • Rice Hall James & Associates's largest Q3 2017 buy was Knight Transportation: 520,189 shares worth $21.6M.
  • Rice Hall James & Associates added most to Dave & Buster's in Q3 2017, an estimated $16.9M increase.
  • Rice Hall James & Associates's biggest Q3 2017 reduction was Stamps.com, Inc., cutting an estimated $18.9M.
  • Rice Hall James & Associates fully exited Electronics for Imaging in Q3 2017, selling an estimated $27M.
  • Rice Hall James & Associates's ten largest holdings make up 17% of its $2.26B portfolio in Q3 2017.
  • Rice Hall James & Associates opened 24 new positions and closed 22 in Q3 2017.
  • Rice Hall James & Associates's portfolio value fell 1.7% quarter-over-quarter to $2.26B.

Based on Rice Hall James & Associates's 13F filing for Q3 2017, filed 30 Oct 2017.